Obsessive-compulsive symptoms in schizophrenia during treatment with clozapine and classic antipsychotic drugs;Síntomas obsesivo-compulsivos en esquizofrenia durante el tratamiento con clozapina y antipsicóticos clásicos

Actas Espanolas de Psiquiatria

Volumn 32, Issue 4, 2004, Pages 211-215

  Galvez Buccollini J A ^a,c   Fiestas, F ^a   Herrera, P ^a   Vega Dienstmaier, J M ^a   Guimas, B ^a,b   Mazzotti, G ^a  

^a UNIVERSIDAD PERUANA CAYETANO HEREDIA   (Peru)

^b Inst Especializado Salud Mental H   (Peru)

^c Urban Olimpo Distrito Ate ^*  (Peru)

Author keywords

Classic antipsychotic drugs; Clozapine; Obsessive compulsive disorder; Obsessive compulsive symptoms; Schizophrenia

Indexed keywords

CLOZAPINE; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MEDICAL ASSESSMENT; MENTAL HEALTH CENTER; OBSESSIVE COMPULSIVE DISORDER; OUTPATIENT; RATING SCALE; SCHIZOPHRENIA; STATISTICAL SIGNIFICANCE; TECHNIQUE; TREATMENT OUTCOME;

ADULT; ANTIPSYCHOTIC AGENTS; CLOZAPINE; FEMALE; HUMANS; MALE; OBSESSIVE-COMPULSIVE DISORDER; SCHIZOPHRENIA;

EID: 4143118989     PISSN: 11399287     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Tibbo P, Warneke L. Obsessive-compulsive disorder in schizophrenia: epidemiologic and biologic overlap. J Psychiatry Neurosci 1999;24:15-24.
2. Poyurovsky M, Hramenkov S, Isakov V, Rauchverger B, Modai I, Schneidman M, et al. Obsessive-compulsive disorder in hospitalized patients with chronic schizophrenia. Psychiatry Res 2001;102:49-57.
3. Poyurovsky M. Obsessive-compulsive disorder in patients with first episode schizophrenia. Am J Psychiatry 1999; 156:1998-2000.
4. Levkovitch Y, Kronnenberg Y, Gaoni B. Can clozapine trigger OCD? J Am Acad Child Adolesc Psychiatry 1995; 34:263.
5. Linszen DH, de Hann L, Gorsira R. Clozapine and obsessions in patients with recent-onset schizophrenia and other psychotic disorders. J Clin Psychiatry 1999;60:364-5.
6. Patil VJ. Development of transient obsessive-compulsive symptoms during treatment with clozapine. Am J Psychiatry 1992;149:272.
7. Baker RW, Ames D, Umbricht DS, Chengappa KN, Schooler NR. Obsessive-compulsive symptoms in schizophrenia: a comparison of olanzapine and placebo. Psychopharmacol Bull 1996;32:89-93.
8. Cassady SL, Thaker GK. Addition of fluoxetine to clozapine. Am J Psychiatry 1992;149:1274.
9. Biondi M, Fedele L, Arcangeli T, Pancheri P. Development of obsessive-compulsive symptoms during clozapine treatment in schizophrenia and its positive response to clomipramine. Psychother Psychosom 1999;68:111-2.
10. Poyurovsky M, Bergman Y, Shoshani D, Schneidman M, Weizman A. Emergence of obsessive-compulsive symptoms and tics during clozapine withdrawal. Clin Neuropharmacol 1998;21:97-100.
11. Ghaemi SN, Zarate CA Jr, Popli AP, Pillay SS, Cole JO. Is there relationship between clozapine and obsessive-compulsive disorder?: a retrospective chart review. Compr Psychiatry 1995;36:267-70.
12. Baker RW, Chengappa KN, Baird JW, Steingard S, Christ MA, Schooler NR. Emergence obsessive-compulsive symptoms during treatment with clozapine. J Clin Psychiatry 1992;53:439-42.
13. Linszen D, de Haan L, Beuk N, Hoogenboom B, Dingemans P. Obsessive-compulsive symptoms during treatment with olanzapine and risperidone: a prospective study of 113 patients with recent-onset schizophrenia or related disorders. J Clin Psychiatry 2002;63:104-7.
14. Poyurovsky M, Hermesh H, Weizman A. Fluvoxamine treatment in clozapine-induced obsessive-compulsive symptoms in schizophrenic patients. Clin Neuropharmacol 1996; 19:305-13.
15. Tibbo P, Kroetsch M, Chue P, Warneke L. Obsessive-compulsive disorder in schizophrenia. J Psychiatr Res 2000;34: 139-46.
16. Porto L, Bermanzohn P, Siris S, Pollack S, Morrisey R. A profile of obsessive compulsive symptoms in schizophrenia. Schizophr Res 1997;24:24-20.
17. Kozak MJ, Goodman WK, Liebowitz M, White KL. Treatment of obsessive-compulsive disorder with fluvoxamine: a multicentre, double-blind, placebo-controlled trial. Int Clin Psychopharmacol 1996;11:21-9.